a public good project by the
Synthesis
Company
of California

© 2026

Robert A. Hegele | doi.page

0 works0 citations0 h-index

Robert A. Hegele

Western University(CA)

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Lipid metabolism and disorders, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, Genetic Associations and Epidemiology

Most-Cited Works

→ Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel(2017)3,675 cited
→ Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society(2013)2,699 cited
→ Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel(2020)1,462 cited
→ Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management(2015)1,387 cited
→ 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult(2016)1,174 cited
→

Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

(2000)

1,068 cited

→ Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society(2014)1,034 cited

→ Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment(2015)846 cited

→ Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society(2021)833 cited

→ 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults(2021)814 cited